ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus

Suresh Babu Kondaveeti, Ivvala Anand Shaker.



Abstract
Download PDF Post

Introduction: Since glycated albumin (GA) reflects with short term variations and these glycated protein shows degree of hyperglycemia, the objective of the study is to find GA and microalbuminuria as an early risk markers along with the duration of uncontrolled diabetes mellitus in type 2 diabetic nephropathy.
Materials and Methods: The present cross-sectional study included randomly selected uncontrolled type 2 DM [n=75], controlled type 2 DM [n=75] and healthy controls [n=75]. The fasting venous blood was obtained for GA and serum creatinine, while their morning urine sample was obtained for detection of microalbuminuria. Statistical analysis was done using SPSS version 16.0. One-Way ANOVA was performed. All p-values < 0.05 were considered as statistically significant.
Results: The mean GA, microalbuminuria and serum creatinine were the highest in uncontrolled DM when compared with controlled DM respectively. Microalbuminuria and GA had a significant correlation with duration of diabetes (p

Key words: Glycated albumin; microalbuminuria; diabetic nephropathy.







Bibliomed Article Statistics

25
41
38
28
33
55
32
122
32
24
34
23
R
E
A
D
S

9

16

5

12

16

75

17

17

15

11

10

5
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.